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Resistance Evolution against Phage Combinations Depends on
the Timing and Order of Exposure
Rosanna C. T. Wright,a,b Ville-Petri Friman,a Margaret C. M. Smith,a Michael A. Brockhurstb
aDepartment of Biology, University of York, York, United Kingdom
bDepartment of Animal and Plant Sciences, University of Sheffield, Sheffield, United Kingdom
ABSTRACT Phage therapy is a promising alternative to chemotherapeutic antibiot-
ics for the treatment of bacterial infections. However, despite recent clinical uses of
combinations of phages to treat multidrug-resistant infections, a mechanistic under-
standing of how bacteria evolve resistance against multiple phages is lacking, limit-
ing our ability to deploy phage combinations optimally. Here, we show, using Pseu-
domonas aeruginosa and pairs of phages targeting shared or distinct surface receptors,
that the timing and order of phage exposure determine the strength, cost, and mu-
tational basis of resistance. Whereas sequential exposure allowed bacteria to acquire
multiple resistance mutations effective against both phages, this evolutionary trajec-
tory was prevented by simultaneous exposure, resulting in quantitatively weaker re-
sistance. The order of phage exposure determined the ﬁtness costs of sequential re-
sistance, such that certain sequential orders imposed much higher ﬁtness costs than
the same phage pair in the reverse order. Together, these data suggest that phage
combinations can be optimized to limit the strength of evolved resistances while
maximizing their associated ﬁtness costs to promote the long-term efﬁcacy of phage
therapy.
IMPORTANCE Globally rising rates of antibiotic resistance have renewed interest in
phage therapy where combinations of phages have been successfully used to treat
multidrug-resistant infections. To optimize phage therapy, we ﬁrst need to under-
stand how bacteria evolve resistance against combinations of multiple phages. Here,
we use simple laboratory experiments and genome sequencing to show that the
timing and order of phage exposure determine the strength, cost, and mutational
basis of resistance evolution in the opportunistic pathogen Pseudomonas aeruginosa.
These ﬁndings suggest that phage combinations can be optimized to limit the emer-
gence and persistence of resistance, thereby promoting the long-term usefulness of
phage therapy.
KEYWORDS Pseudomonas aeruginosa, bacteriophage therapy, bacteriophages,
evolutionary biology, resistance evolution
Globally rising rates of resistance against all major classes of chemotherapeuticantibiotics have renewed interest in the therapeutic use of phages to treat bacterial
infections (1, 2). However, like antibiotics, the evolution of bacterial resistance to
phages could limit the long-term sustainability of phage-based treatments (3). There-
fore, it is important to understand the evolutionary processes determining the emer-
gence of bacterial resistance against phage infection. Phages initiate infection by
binding to molecules on the bacterial cell surface in a process called adsorption, so a
common form of resistance is to prevent adsorption by modifying the targeted surface
molecule(s) that acts as a phage receptor(s) (4–6). This can involve mutations affecting
the regulation or biosynthesis of the surface molecule, leading to loss or altered
structure of the receptor (6–8). Because the targeted surface molecules usually serve
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other functions—for instance, motility, cell membrane integrity, or nutrient transport—
their alteration or loss is frequently associated with ﬁtness costs, which can limit the
success of resistant mutants in the absence of phages (9, 10).
Resistance mutations against a single phage typically occur at high frequency, and
due to phage killing of susceptible genotypes, these resistance mutations will rapidly
sweep through the bacterial population (8). Consequently, phage therapy usually
involves the application of combinations of multiple phages, which is believed to limit
the emergence of resistance in addition to targeting a wider range of bacterial
genotypes (11, 12). There are two potential explanations for why phage combinations
could limit the evolution of resistance. First, resistance to multiple phages may require
multiple resistance mutations to arise in the same cell (13, 14), which is likely to occur
with very low probability. Second, due to their associated ﬁtness costs, the accumula-
tion of multiple resistance mutations could lead to substantial loss of ﬁtness if costs
interact additively or synergistically (9, 10, 15, 16), reducing the ability of resistant cells
to persist when faced with competition by nonresistant cells.
The evolution of resistance against phage combinations could occur more readily if
individual resistance mutations protected against more than one phage, a property
called cross-resistance. Cross-resistance is most likely to be elicited between phages
that target the same bacterial surface receptor, where resistance mutations causing
modiﬁcation or loss of the shared receptor prevent the adsorption of each of the
phages (7, 17, 18). Consequently, it is likely that successful phage combinations will
tend to be those including phages that target multiple, distinct cell surface receptors
because this will limit the potential for cross-resistance (14, 18). Moreover, although
generalist cross-resistance mutations in global transcriptional regulators protecting
against phages binding distinct receptors have been reported, these mutations oc-
curred at lower frequency and incurred much higher costs than those affecting only a
single receptor (7, 18).
Application of multiple phages in combinations either simultaneously or sequen-
tially could also affect the trajectory of resistance evolution (7, 17, 19). Previous
experimental studies suggest that sequential exposure can be as effective as applying
phages simultaneously, but it was not tested whether these treatments selected for
qualitatively different resistance mutations (17). It is likely that resistances selected
under sequential versus simultaneous phage exposure will differ: sequential exposure
provides more opportunity to accumulate multiple, speciﬁc resistance mutations,
whereas simultaneous exposure may be more likely to select for a single, generalist
cross-resistance mutation. Additionally, phage exposure prior to antibiotic treatment
has been shown to improve bacterial killing more than either simultaneous treatment
or the reverse order (i.e., antibiotic ﬁrst [20, 21]). This suggests that the order in which
antibacterial treatments are applied can have important effects on their efﬁcacy, but
the effect on the evolution of resistance to phage combinations remains unclear.
Here, we test experimentally how the evolution, genetic basis, and cost of resistance
against pairs of phages targeting either the same or different cell surface receptors
(lipopolysaccharide [LPS] and type IV pilus) in the Pseudomonas aeruginosa PAO1 strain
depends on the timing and order effects when phages are applied in one step (i.e.,
simultaneous exposure) or sequentially. We found that sequential exposure allowed
accumulation of multiple phage-speciﬁc resistances provided by mutations in cell
surface receptor targets of phage adsorption without imposing any trade-offs in the
strength of resistance. The order of phage exposure determined the ﬁtness costs of
sequential resistance, such that certain sequential orders imposed much higher ﬁtness
costs than the same phage pair in the reverse order. In contrast, simultaneous selection
for phage resistances resulted in weaker resistance to both phages compared to the
strength of sequentially acquired resistance with similar ﬁtness costs. This suggests that
phage combination treatments can be rationally designed to limit the strength of
evolved resistances and to maximize ﬁtness costs associated with resistance.
(Parts of this work were presented as a thesis for Rosanna C. T. Wright at the
University of York.)
Wright et al. ®
September/October 2019 Volume 10 Issue 5 e01652-19 mbio.asm.org 2
 o
n
 O
ctober 22, 2019 at PERIO
DICALS O
FFICE, M
AIN LIBRARY, UNIVERSITY O
F SHEFFIELD
http://m
bio.asm
.org/
D
ow
nloaded from
 
RESULTS
Sequential resistance is rarely limited by a trade-off in resistance strength. By
exposing the bacterial host to different phages sequentially, we could assess how the
strength of resistance to each phage was inﬂuenced by the order of phage exposure.
For a pair of phages targeting lipopolysaccharide (LPS) receptors (PA10P2 and 14/1), we
typically found that the ﬁrst-step resistance mutation provided resistance to both
phages of approximately equivalent strength (Fig. 1A, Tukey test on analysis of variance
[ANOVA] interaction, P  0.99 in ﬁve out of six replicates). Hence, sequential selection
for second-step resistance to the alternate LPS-associated phage did not tend to
increase resistance against this second phage (Fig. 1A, Tukey test on ANOVA interac-
tion, all P  0.1). Moreover, after the second step of sequential selection, we observed
only minimal trade-offs in resistance to the ﬁrst phage (maximum decrease of 15%).
Nonetheless, the order of exposure to phages appeared to have an effect on the
occurrence of trade-offs: whereas no trade-off was observed in 14/1 resistance follow-
ing second-step sequential selection of PA10P2 resistance (Fig. 1A, Tukey test on
ANOVA interaction, all P  0.1), PA10P2 resistance was slightly reduced following
second-step sequential selection of 14/1 resistance in two out of three replicates
(Fig. 1A, Tukey test on ANOVA interaction, mean differences of 0.140 and 0.259,
both P  0.001).
In contrast, for pairs of phages that targeted different receptors, that is either the
LPS or the type IV pilus, the ﬁrst-step resistance mutation rarely provided effective
cross-resistance to the second-step phage. Whereas ﬁrst-step resistance mutations
against phage targeting LPS (PA10P2 or 14/1) provided weak cross-resistance to the
type IV pilus-associated phage (PA5P2) in two out of six replicates (Fig. 1B and C, Tukey
test on ANOVA interactions, P  0.010 and 0.001), ﬁrst-step resistance mutations
against PA5P2 provided no cross-resistance against the LPS-binding phages. This
suggests that, unlike for the phage pairs that shared the LPS receptor, multiple
resistance mutations were required to protect against sequential phage pairs that
targeted different receptors (Fig. 1B and C, Tukey test on ANOVA interaction, resistance
to second phage after ﬁrst step versus second step, all P  0.001). However, the
strength of the ﬁrst-step resistance was rarely reduced following sequential selection
for the second-step resistance (1 out of 12 replicates). Indeed, we observed increases in
the strength of the ﬁrst-step resistance in half of the replicates following acquisition of
the second-step resistance mutation (Fig. 1B and C, Tukey test on ANOVA interaction,
all P  0.001). This implies that when phages target different receptors, sequential
phage selection leads to additive resistances that rarely impose trade-offs in the
strength of resistance to phages that adsorb to different cell surface receptors.
Simultaneous phage selection results in weak resistance to both phages. To
determine whether equivalent resistances against pairs of phages could be achieved in
one step rather than two sequential steps, we also selected resistant mutants against
each phage pair simultaneously. Simultaneous selection by the phage pair targeting
the LPS generally resulted in weaker resistance compared to the ﬁrst-step and second-
step resistance mutations observed during sequential selection with the same phages
(Fig. 1A, Tukey test on ANOVA interaction, simultaneous selection weaker than ﬁrst-step
sequential selection in ﬁve of six replicates, P  0.05; simultaneous selection weaker
than second-step sequential selection in ﬁve of six replicates, P  0.05). Similarly,
simultaneous selection for resistance against the phage pairs targeting different recep-
tors consistently resulted in weaker resistance to both phages compared to sequential
resistance selection (Fig. 1B and C; Tukey test on ANOVA interactions, for PA5P2
resistance, all replicates weaker with P  0.005; for PA10P2 resistance, three of six
replicates weaker with P  0.05; for 14/1 resistance, all replicates weaker with P  0.05).
Together, these results indicate that simultaneous exposure to multiple phages can
reduce the strength of evolved resistance, even when the phage strains target the same
receptor and promote reciprocal cross-resistance.
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FIG 1 Trade-offs in the strength of resistance to each phage combination. Strength of resistance,
measured as reduction in bacterial growth (RBG  standard error [SE]), such that 1 indicates equal
growth in the presence and absence of phage. Selection treatment for focal resistance is indicated by
color (see individual keys). Background shading indicates the mean resistance strength for the ﬁrst step
in sequential resistance treatments to highlight changes in resistance to the ﬁrst-step phage in the
second step of sequential selection treatments.
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Cost of resistance against multiple phages is determined by the order of
applied phages. The emergence of highly resistant bacteria could be limited if strong
resistance against multiple phages arising from sequential acquisition of resistance
mutations was associated with higher costs (i.e., lower relative ﬁtness). Thus, we next
compared the growth kinetics of the resistant mutants relative to the phage-
susceptible ancestral bacterial genotypes. Sequential resistance was more costly than
equivalent simultaneous resistance in nearly half of replicates; however, we also
observed that sequential resistance could impose equal or lower costs than equivalent
simultaneous resistance (Fig. 2; Tukey test on ANOVA interactions, sequential resistance
more costly in 6/13 replicates, P  0.05; sequential resistance less costly in 2/13
replicates, P  0.05; no signiﬁcant difference in 5/13 replicates). This suggests that
strong resistance against multiple phages can often be acquired sequentially without
additional cost compared to weaker resistance acquired under simultaneous phage
exposure. Nonetheless, order effects were important in determining the cost of resis-
tance for some sequential resistances. When the ﬁrst-step resistance was against a type
IV pilus-binding phage followed by second-step resistance against a LPS-binding
phage, we observed signiﬁcant reductions in relative ﬁtness following the second step
in half of the replicates (Fig. 2B and C, Tukey test on ANOVA interaction, 3/6 replicates
P  0.05), whereas no signiﬁcant change in ﬁtness cost was observed with the opposite
order of phage selection (i.e., exposure to ﬁrst LPS-binding phage and then type IV
pilus-binding phage). This suggests that the cost of resistance is mutation speciﬁc, and
ﬁtness can be determined by order effects indicative of epistatic interactions between
speciﬁc resistance mutations.
Genetic basis of phage resistance after sequential versus simultaneous phage
selection. To assess how the genetic basis of resistance varied between phage selec-
tion treatments, we sequenced the whole genomes of three resistant mutants exposed
to each pairwise combination of the phages PA5P2, PA10P2, and 14/1 under both
sequential and simultaneous selection regimes. Whereas single-phage resistance (i.e.,
ﬁrst step of sequential selection) promoted acquisition of single mutations, selection of
multiple phage resistances was generally provided by multiple resistance mutations in
both simultaneous and sequential selection regimes (Tukey test on ANOVA interaction,
second-step sequential selection versus ﬁrst-step sequential selection, diff  1.20, P 
0.0001; simultaneous versus ﬁrst-step sequential, diff  1.18, P  0.001; simultaneous
selection versus second-step sequential selection, diff  0.018, P  0.997).
For sequential resistance, we found that the ﬁrst step resistance against all phages
relied upon single variants in receptor-speciﬁc genes (Fig. 3A; see Table S1 in the
supplemental material), with only one case of a secondary mutation which was likely
due to hitch-hiking. Most mutations conferring ﬁrst-step resistance to LPS-binding
phages (PA10P2 and 14/1) targeted the wzy gene, which encodes a polymerase
involved in synthesis of the LPS B-band O antigen (Table S1). All ﬁrst-step resistance
mutants selected using the type IV pilus-binding phage PA5P2 carried a single muta-
tion affecting type IV pilus-associated genes (Fig. 3A; Table S1), including pilB (encoding
a motor protein controlling pilus extension), pilN (encoding a product involved in pilus
assembly), and pilR (encoding part of a two-component system regulating pilin pro-
duction).
Sequential resistance against combinations of phages targeting different receptors
required a combination of two mutations, each affecting a distinct receptor-speciﬁc
target (Fig. 3B; Table S1). Second-step resistance against the type IV pilus-binding
phage PA5P2 required mutations targeting genes involved in pilus motility (pilT and
pilU), extension and retraction (pilB and pilY1, respectively), and structural pilins (pilE)
(note, however, that for two replicates we were unable to identify the ﬁrst-step mutations
and therefore these sequences were discarded). Second-step resistance against an
LPS-binding phage (PA10P2 or 14/1) commonly required secondary mutations in wzy,
the same gene that provided ﬁrst-step resistance against these phages. Interestingly,
however, in two out of three replicates of sequential selection with PA5P2 followed by
14/1, we observed second-step mutations in a distinct target, galU, a uridylyltransferase
Resistance Evolution against Phage Combinations ®
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FIG 2 Relative ﬁtness of resistant mutants is determined by selection regime. Fitness is measured as the maximum growth rate
achieved during a 48-h growth period and given relative to that of the ancestral genotype; a value above 1 (light gray
(Continued on next page)
Wright et al. ®
September/October 2019 Volume 10 Issue 5 e01652-19 mbio.asm.org 6
 o
n
 O
ctober 22, 2019 at PERIO
DICALS O
FFICE, M
AIN LIBRARY, UNIVERSITY O
F SHEFFIELD
http://m
bio.asm
.org/
D
ow
nloaded from
 
involved in LPS biosynthesis. Additional mutations in non-receptor-speciﬁc genes were
found in three out of six replicates where resistance to the type IV pilus-associated
phage was followed by sequential LPS-associated resistance, while no additional
mutations were found in the reverse treatment order (i.e., LPS followed by type IV pilus)
(Fig. 3B; Table S1). Taken together, these genetic data conﬁrm that trade-offs in
resistance strength between combinations of phages that bind different receptors were
uncommon when resistance was acquired sequentially because multiple receptor-
speciﬁc mutations were acquired, providing additive resistance.
In the case of sequential selection by pairs of phages targeting the same receptor,
we observed order effects for the number and target of resistance mutations. Only one
mutation was detected per replicate following sequential selection with phage 14/1
followed by PA10P2, whereas for the reverse order, we observed additional mutations
in the second-step mutants (Fig. 3B; Table S1). For two replicates, we observed mutations
in a gene of unknown function, PA0429, while the third replicate gained a second
LPS-associated mutation (wapH, predicted glycosyl transferase; Table S1). It is unclear
why parallel mutations in PA0429 would be selected because they provided no increase
in resistance to 14/1 (in fact, the ﬁrst-step resistance mutations in these replicates
already provided strong cross-resistance to 14/1; Fig. 1), nor any reduction of the
associated ﬁtness costs (Fig. 4; Tukey test on ANOVA, wzy versus wzy plus PA0429, P 
0.978). In contrast, the wapH mutation did improve 14/1 resistance; here the ﬁrst-step
resistance mutation in the LPS biosynthesis gene rml, encoding a thymidylyltransferase,
provided weak cross-resistance to 14/1 (Tukey test on ANOVA, strength of focal
resistance versus cross-resistance, diff  0.463, P  0.0001), and furthermore, gaining
the second-step resistance mutation was not associated with any increase in ﬁtness
costs (Fig. 4; Tukey test on ANOVA, rmlA versus rmlA plus wapH, P  1).
In contrast, accumulation of multiple receptor-speciﬁc resistance mutations was
never observed when phage pairs that targeted type IV pilus or LPS receptors were
applied simultaneously (Fig. 3C). Half of the resistant mutants resulting from simulta-
neous exposure to phage pairs with different receptor targets carried mutations in
LPS-associated genes without any additional type IV pilus-speciﬁc mutations (Fig. 3C).
Surprisingly, we were unable to identify any mutations in two out of six replicates,
suggesting that these clones had either displayed phenotypic resistance or had sub-
sequently undergone a reversion mutation to restore phage sensitivity. In two resis-
tance mutants, we observed duplication of the same two genes (approximately 1 Mb
apart) both linked with DNA recombination: one encoding a single-strand DNA-binding
protein (ssb) and the other a putative exonuclease (PA3263). However, the relationship
between gene duplication and phage resistance is currently unclear.
Despite LPS-binding phages promoting strong reciprocal cross-resistance, two out
of three resistance mutants selected against phages PA10P2 and 14/1 simultaneously
had secondary mutations in non-LPS genes in addition to LPS-associated mutations.
One mutant had a large deletion of approximately 250 kbp (around 4% of the whole
genome), affecting more than 200 genes, including galU, the LPS biosynthesis gene
that was also mutated under sequential selection against PA5P2 and 14/1 (Fig. 3C). This
indicates that while PA10P2 and 14/1 both adsorb to the LPS, they probably target
different sites, such that the strength of cross-resistance depends on speciﬁc effects of
mutations on the LPS structure.
Fitness costs associated with specific resistance mutations. Across all genome-
sequenced resistant mutants, those that had acquired multiple resistance mutations were
less ﬁt than those with only single resistance mutations (t test, t93.2  4.63, P  0.0005).
FIG 2 Legend (Continued)
background) indicates lack of ﬁtness costs associated with resistance mutation(s). Data points indicate the means of three
technical replicates (SE) measured for each set of biological replicates (plot headings indicate ancestral genotype used in the
ﬂuctuation test). Selection treatment for focal resistances is indicated by color (see individual keys). The mean relative ﬁtness of
simultaneous selection treatments is shown as a dashed purple line, with light purple shading to indicate standard error. Missing
data indicate that no resistant mutants were recovered for that replicate treatment.
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Fitness costs were often additive for combinations of LPS and type IV pilus mutations,
with pairs of resistance mutations imposing greater costs than single resistance muta-
tions on their own (Fig. 4). Second-step mutations in the LPS-associated gene galU
increased ﬁtness costs in combination with ﬁrst-step mutations in type IV pilus genes
(Fig. 4, Tukey test on ANOVA, pilN versus pilN plus galU, P  0.0001; pilR versus pilR plus
galU, P  0.0001), but this was not the case for wzy which imposed no additional cost
FIG 3 Treatment regimes determine the frequency and type of resistance mutations selected. Total number of identiﬁed mutations per
resistant mutant across phage selection treatments (plot headings) under single (A), sequential (B), or simultaneous (C) selection. Colors
indicate category of mutational target (see key).
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(Fig. 4, Tukey test on ANOVA, pilR versus pilR plus wzy, P  0.826). Similarly, for
sequential resistance selected against the pair of LPS-binding phages, secondary
mutations in both LPS and non-LPS targets were effectively cost-free (Fig. 4, Tukey test
on ANOVA, wzy versus wzy plus PA0429, P  0.978; rmlA versus rmlA plus wapH, P 
1.00). While we were unable to calculate epistatic effects for most double mutants, as
different loci were targeted in respective stages of sequential selection or multiple
mutations were acquired concurrently, these results indicate that ﬁtness costs of
sequential resistance against multiple phages are likely to depend on epistatic inter-
actions between the speciﬁc multiple resistance mutations.
DISCUSSION
We compared the evolutionary trajectory of phage resistance selected sequentially
versus simultaneously against pairs of phages targeting either the same or different cell
surface receptors required for adsorption and infection of the bacterial cell. Sequential
resistance to phage combinations targeting different receptors was acquired by accu-
mulation of multiple receptor-speciﬁc mutations which promoted strong additive
resistance to both phage strains without trade-offs in the strength of resistance to each
phage. In comparison, simultaneous exposure to multiple phages resulted in weaker
resistance to both phages through either single receptor-speciﬁc mutations or other
major genetic variations (i.e., deletion and duplication events) affecting a larger number
of genes. Furthermore, although sequentially acquired resistance was generally much
stronger, it often imposed no greater cost to host ﬁtness than the corresponding
(weaker) simultaneous resistance. This suggests that simultaneous phage exposure
imposes far greater constraint on resistance evolution than sequential exposure, lead-
ing to weaker resistance at the same ﬁtness cost, which would be highly beneﬁcial
when applying phages in a therapeutic context.
FIG 4 Contrasting ﬁtness costs resulting from speciﬁc combinations of single and double mutations. Fitness
relative to the ancestor, where a value of 1 indicates equal ﬁtness and a value below 1 indicates a ﬁtness cost
associated with labeled single (left panel) or double (right panel) mutations. The dashed line indicates predicted
additive cost of two mutations affecting different receptors, given as the sum of the mean cost of individual
receptor-speciﬁc mutations (gray band; single LPS mutations RF  0.886, single type IV pilus-speciﬁc mutations RF
 0.880).
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Phages targeting the same receptor (LPS) provided strong cross-resistance to one
another, such that the ﬁrst step of sequential resistance provided equally strong
resistance to both LPS-binding phages through acquisition of a single mutation affect-
ing LPS biosynthesis, irrespective of the focal LPS-binding phage used to select
resistance. We therefore expected that simultaneous and second-step sequential se-
lection against two LPS-binding phages would be equivalent to the ﬁrst step of
sequential selection. Consistent with this, under sequential selection, resistance to both
LPS-binding phages was provided by single mutations in LPS biosynthesis-associated
genes, and although second-step mutations were observed upon second-step expo-
sure to 14/1 (in PA0429), this mutation affected neither resistance or ﬁtness. In contrast,
under simultaneous exposure, multiple resistance mutations were observed in two out
of three replicates, one of which was a large deletion affecting approximately 4% of the
host genome. This suggests that even when phages target the same receptor, subtle
differences in their target sites may make it harder to resist both phages simultaneously
through a single mutation, even though single mutations providing resistance to both
phages are available when encountered individually.
For combinations of phages targeting different receptors, we found that the order
of exposure to phages could determine the trajectory of resistance evolution and its
associated ﬁtness costs. Sequential exposure to an LPS-binding phage following a type
IV pilus-binding phage decreased the relative ﬁtness of the host, whereas there was no
signiﬁcant change in the cost between the two stages of sequential exposure in the
reverse order (i.e., type IV pilus-binding phage after LPS-binding phage). Similar type IV
pilus mutations were selected in both sequential treatment orders, commonly affecting
gene products involved in pilus-dependent motility [e.g., pilB, pilT, and pilU encode
motor proteins, and pilY1 encodes an anti-retraction factor [22, 23]). The LPS biosyn-
thesis gene wzy (24) was targeted in both sequential treatments but imposed only
modest increases in ﬁtness cost, whereas mutations in galU, a uridylyltransferase also
involved in LPS biosynthesis (25), were selected twice under selection with the LPS-
binding phage 14/1 following initial selection against the type IV pilus-binding phage
PA5P2 and caused severe decreases in bacterial ﬁtness. Whereas mutations in wzy often
affect only the B-band of LPS (13, 26), galU mutations may cause broader structural
changes, affecting both the LPS core and A-band (27), which may explain their more
detrimental effect on bacterial ﬁtness. Additionally, it is possible that some primary
mutations limit the acquisition of secondary mutations, for example, in second-step
clones exposed to type IV pilus-binding phage PA5P2, we were unable to detect the
LPS-associated mutations in rmlA and ssg present in the ﬁrst-step sequenced clone (28,
29). Strong negative epistatic interactions between receptor-speciﬁc resistant muta-
tions could limit or prevent the survival of bacteria carrying both mutations (although
it should be noted that our experimental design did not permit direct measurement of
epistatic interactions). Taken together, these data suggest that sequential selection
with type IV pilus-binding phage followed by LPS-binding phage may both decrease
the likelihood of multiple phage resistance genotypes arising and impose substantial
ﬁtness costs upon those cells that do evolve resistance, which may be sufﬁcient to allow
eradication of the infection by antibiotic treatment, or even by the patient’s own
immune system. Rational design of sequential phage treatments to optimize these
types of order effects could direct the trajectory of resistance evolution, allowing high
ﬁtness costs to be promoted and limiting ﬁxation of certain resistance mutations.
Compared to sequential selection of resistance, simultaneous exposure promoted
acquisition of weaker resistance. Whereas sequential resistances in different receptor
targets provided additive resistance, simultaneous exposure often led to single
receptor-speciﬁc mutations which provided relatively weak resistance to only one of
the phages, or more-complex mutational effects (e.g., duplication and deletion events)
targeting many genes, including some not known to be associated with LPS or type IV
pilus. Although large deletions have been previously reported to provide phage
resistance in vitro (30, 31), the loss of a large number of genes is likely to have major
pleiotropic effects in more-complex environments where bacteria must respond to
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various environmental stressors (32, 33) and may be inﬂuenced by the resident micro-
ﬂora (34). Additionally, single mutations that do not provide resistance to all phages
present in the cocktail may not be sufﬁcient to allow survival under sustained phage
pressure (e.g., if phage propagate in vivo). Overall, this suggests that there are fewer
mutational routes allowing bacteria to survive in the presence of multiple phages
simultaneously.
Bacterial phenotypic responses to stressors may also explain why we were unable to
identify resistance mutations in some hosts exposed simultaneously to multiple phage
strains. Stochastic environmental changes which affect bacterial lifestyle traits can
hinder phage infection in numerous ways and create heterogeneity in host phenotypes
within a population (35): changes in temperature can affect the rigidity of the host cell
membrane, preventing phage infection (36), and nutrient variability can reduce expres-
sion of phage receptors (37–39). Changes in receptor expression levels could poten-
tially limit phage adsorption sufﬁciently to enable survival of the host under simulta-
neous selection with multiple phage strains without leaving a genetic trace (40). Such
resistances may be incidental to phage infection or induced by phage products in the
environment and/or products of cellular lysis and may be considered phenotypic phage
resistance (35, 37). Alternatively, survival in the presence of multiple phages may
require such costly resistance mutations that as soon as phage selection pressures are
relieved, reversion mutants restoring the original genotype rapidly outcompete the
resistant genotype as the colony grows (41, 42). Although reversion is often much less
likely than acquisition of compensatory mutations (43), we saw little evidence of
compensatory mutations in our experiment; however, we did observe secondary
mutations in genes of unknown function that arose concurrently with receptor-speciﬁc
mutations, suggesting that compensation may be occurring. Ecological factors that
inﬂuence population densities, adaptation responses, and stress-mediated effects may
inﬂuence both the accumulation and persistence of phage resistance mutations by
potentially promoting phenotypic resistance or rapid compensation; therefore, a better
understanding of these interactions is required to design more durable phage thera-
peutics.
There are several caveats with respect to the wider implications of this work. First,
we were largely unable to isolate resistant mutants against the pilus-binding phage
PT7, suggesting that strong phage identity effects may overwhelm the effect of phage
order and timing of exposure. It is possible that resistance mutations against PT7 are
very rare or incur such high ﬁtness costs that resistant mutants do not survive. Second,
we consider here the emergence of spontaneous resistance mutations only during
short 48-h incubations; different patterns of resistance could emerge over longer time
periods, offering more opportunity for a wider range of mutations to arise, including
compensatory mutations to ameliorate ﬁtness costs. Third, we used only a limited
number of phage strains targeting just two distinct bacterial receptors. To determine
whether the principles of resistance emergence observed here can be generalized,
future work will be needed to test a wider range of genetic and functional diversity of
phages, including those binding a wider range of receptors, and to determine the
contribution of other modalities of phage resistance in the bacterial hosts, for instance,
CRISPR-Cas systems.
In conclusion, we found that the ﬁtness cost of multiphage resistance could be
maximized under speciﬁc orders of phage exposure by selecting for type IV pilus-
associated resistance mutants followed by LPS-associated resistance mutants. As ﬁtness
costs are potentially exacerbated in vivo, due to more-intense competition for resources
and the requirement of expression of a broader range of traits (44, 45), maximizing
ﬁtness costs associated with phage resistance could reduce the long-term success of
resistant mutants. On the other hand, simultaneous exposure to multiple phage strains
often imposed similar costs to sequential treatments but for weaker resistance against
the phage combination. Due to the potential for phages to propagate and evolve to
overcome bacterial resistance during treatment by replicating on susceptible bacteria,
limiting the strength of evolved resistance may be just as beneﬁcial as maximizing host
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ﬁtness costs. Further experiments are warranted to determine the relative importance
of these effects in vivo, as more-complex environmental pressures may exacerbate
ﬁtness costs and buffer differences in resistance strength. However, these results
highlight that the rational design of phage cocktails to target multiple bacterial targets
can limit the evolution of strong phage resistance and determine the ﬁtness cost of
evolved resistance.
MATERIALS AND METHODS
Strains and culture conditions. Bacterial cultures of P. aeruginosa PAO1 were grown in King’s
medium B (KB) as 6-ml volumes in a 30-ml glass microcosm with loose plastic ﬁtting lids, and incubated
at 37°C with shaking (180 rpm). Four genetically distinct phage strains with characterized adsorption
targets (18) were used to select phage resistance: PA5P2 and PT7 (type IV pilus-binding phages) and
PA10P2 and 14/1 (LPS-binding phages). Phage cultures were prepared directly from frozen glycerol
stocks, added to approximately 107 cells ml1 of ancestral strain PAO1 from overnight culture and
incubated overnight at 37°C with shaking (180 rpm). Phage stocks were puriﬁed by ﬁltration to remove
bacteria (0.22 m) and stored at 4°C.
Selection of spontaneous phage-resistant mutants. We used a modiﬁed ﬂuctuation test (46) to
select spontaneous phage-resistant mutants against all pairwise phage combinations under both
simultaneous and sequential selection. Three independent bacterial colonies were selected by streaking
out the ancestral bacteria directly from glycerol stock onto KB agar (incubated overnight at 37°C);
colonies were inoculated into 6 ml KB, incubated at 37°C (shaken) for 8 h, and then used to found 10
subpopulations by diluting each culture 10-fold into 10 wells of a 96-well microplate containing KB
medium to a ﬁnal volume of 200 l. Samples of these initial bacterial cultures were also frozen (20%
glycerol, 80°C) to be used for replicates and assigned the names PAO1_FT1, PAO1_FT2, and PAO1_FT3.
For each ancestral replicate, we selected phage resistance against each of the 4 individual phage
strains independently (ﬁrst step of sequential selection) and simultaneously against each possible phage
pair (i.e., 6 different pairwise combinations) by exposing each of the 10 bacterial subpopulations to a
different phage treatment. Bacterial subpopulations were diluted 100-fold into 600 l of phage stock
solution (300 l of each phage for simultaneous selection) in deep-well 96-well plates, giving a multi-
plicity of infection of 100 phage per bacteria at a density of 107 bacterial cells per ml, then plated out
in 60-l volumes onto KB agar. For combinations with low expected mutation frequency, the complete
mixture was plated (i.e., all 600 l in 60-l volumes). Following incubation at 37°C for 24 h, single colonies
were picked from each plate and restreaked onto KB agar to remove phage particles and incubated
overnight. If no colonies were present, the same plates were incubated for a further 24 h at 37°C to allow
slow-growing mutants time to produce colonies, which were then selected and restreaked as before.
Single colonies were selected from streak plates and grown overnight in 6 ml KB, before glycerol stocks
were prepared (20% glycerol, stored at 80°C) and characterized for phage resistance by cross-streaking
against pure stocks of each phage strain on KB agar. For any phage treatments for which no bacterial
colonies could be selected or where selected colonies lacked any phage resistance, the whole selection
process was repeated using the same initial ancestral clone, inoculated directly from the glycerol stock
to produce bacterial subpopulations. One clone per ancestral replicate was then chosen for further
characterization (i.e., resistance strength, ﬁtness costs, and sequence analysis), based on initial cross-
streaking results. This produced a total of 12 resistant mutants selected against single phage strains (ﬁrst
step sequential selection – 3 ancestral replicates  4 phage strains), and 18 resistant mutants selected
against two phages simultaneously (i.e., 3 ancestral replicates  6 pairwise phage combinations).
To complete sequential selection, we next exposed resistant bacteria selected against individual
phages (i.e., ﬁrst-step sequential selection) to each additional phage strain (second-step sequential
selection). Clones selected in the ﬁrst step of sequential selection were inoculated directly from glycerol
stocks into 6 ml KB, grown for 8 h at 37°C, and then diluted 10-fold into 3 wells of a 96-well plate to found
3 subpopulations per clone, which were used to select second-step sequential resistance against each of
the other phage strains using the same protocol as above. This produced a further 36 resistant mutants
(3 ancestral replicates  4 ﬁrst-step phages  3 second-step phages). As before, experiments with any
clones lacking phage resistance or phage treatments producing no viable colonies were repeated. This
was mainly an issue for combinations including phages PA5P2 and PT7 (both type IV pilus binding): up
to 75% of populations yielded no resistant mutants, further compounded by a lack of “true” resistance
in the selected colonies (up to 90% of selected colonies lacking quantitative resistance when selected
against combinations including PT7 or PA5P2). Selection treatments including phage PT7 had extremely
low mutation frequencies (e.g., 1 colony on 100 agar plates) and a high error rate both due to lack of
phage resistance in selected PAO1 colonies and bacterial contamination (non-PAO1 colonies; this does
not affect other treatments, as all resistant mutants presented were conﬁrmed to be PAO1 using
whole-genome sequencing). This indicates that true PT7 resistance is very difﬁcult to acquire in
combination with other phage strains, and therefore, treatments containing phage PT7 (under both
sequential and simultaneous selection) were later discarded.
Quantitative resistance assays. To determine the strength of resistance provided by mutations
selected at each stage of sequential selection and by simultaneous exposure to multiple phages, all
spontaneous resistant mutants were assayed against all ancestral phage strains. Resistance assays were
performed in 96-well microplates in KB medium added to a ﬁnal volume of 150 l. A ratio of approxi-
mately 10 phage per bacteria was used, giving densities of 107 bacterial cells and 108 phage particles
per ml (i.e., multiplicity of infection of 10). The strength of resistance was measured as relative bacterial
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growth (RBG) in the presence of phage compared to RBG in the absence of phage (equation 1) (47) such
that a value of 1 indicates complete resistance (i.e., equal growth in the presence and absence of phage).
For resistant mutants with high ﬁtness costs which result in slow growth (e.g., where the lag time may
be up to 8 h), an endpoint of 48 h was used to calculate RBG instead of 8 h.
For phage i, bacteria j,
RBGij 
Abs600t  8 h  Abs600t  0 hij
Abs600t  8 h  Abs600t  0 hcontrolj
(1)
where t denotes time and Abs600 indicates absorbance at 600 nm.
Relative fitness of phage-resistant mutants. To assess the ﬁtness costs imposed by different
resistance mutations, we compared the growth of all resistant mutants to the ancestral PAO1 strain in
the absence of phage. Bacterial cultures were inoculated into 150 l KB medium in 96-well microtiter
plates directly from glycerol stocks and incubated at 37°C with a shaking cycle every 30 min when optical
density was measured as absorbance at 600 nm for a total of 48 h to produce a growth curve. Four
growth parameters were calculated from each growth curve to fully characterize changes in bacterial
growth: the lag time before exponential growth begins, the maximum growth rate, the integral of
the growth curve, and the maximum optical density reached (i.e., yield) (18). To calculate relative ﬁtness,
we used the maximum growth rate, as it correlated well with both the integral and maximum optical
density (see Fig. S1 in the supplemental material). The maximum growth rate for each resistant mutant
was divided by the mean ancestral maximum growth rate (with replicates matched within plates) to give
relative ﬁtness. A relative ﬁtness of 1 indicates equal ﬁtness with the ancestral strain, indicating that any
resistance mutations present impose no ﬁtness costs.
Sequence analysis. All spontaneous phage-resistant mutants were sequenced using the Illumina
MiSeq platform (performed by MicrobesNG, University of Birmingham), and resistance mutations were
detected using the following bioinformatic analysis: short reads were aligned to an annotated PAO1
reference using Burrows-Wheeler Aligner (48), GATK Haplotype Caller (49) was used to identify single
nucleotide polymorphisms (SNPs) and small indel variants, followed by annotation of gene information
using SNPeff (50). Called variants were quality ﬁltered by coverage (20 reads per bp), and frequency of
alternative allele (80% of reads match alternative). Variants that occurred in all replicates were
discarded, as they represent differences between the annotated PAO1 reference genome (GenBank
accession no. or identiﬁer [ID] AE004091) and the ancestral genotype used in our experiments. All
replicates evolved from ancestral clone PAO1_FT3 contained the same SNP in gene PA3676; therefore,
because this mutation must have arisen prior to the ﬂuctuation test (i.e., when individual ancestral
colonies were selected) and imposed no detectable ﬁtness effect, it was ignored in subsequent analyses.
Larger genetic variations, including deletions over 100 bp and duplication events, were identiﬁed by
analyzing changes in coverage depth in R (51), and all variants were veriﬁed visually using an alignment
viewer (52). Variation in the number of mutations acquired under different selection regimes was
assessed using an analysis of variance (ANOVA) with post-hoc Tukey tests, including a main effect of
ancestral replicate. The relative ﬁtness of mutants carrying either single or double resistance mutations
were compared using post-hoc Tukey tests following an ANOVA.
Statistical analysis. The effect of selection regime (i.e., simultaneous selection versus each stage of
sequential selection) on both resistance and relative ﬁtness data were analyzed using multiple ANOVAs
(blocked by ancestral genotype and phage pair) followed by post-hoc Tukey tests. Multiple pairwise
comparisons reported in the Results section were taken from the outputs of these models. Blocking by
ancestral genotype and phage pair identity avoided violation of independence assumptions, i.e., so that
differences between the ancestral genotypes (i.e., PAO1_FT3 has 1 SNP not present in PAO1_FT1 or
PAO1_FT2) and resistance mutations from step 1 of sequential selection are accounted for in these
analyses. In addition, the time at which RBG was calculated (i.e., if 48 h rather than 8 h for slow-growing
resistant mutants with high ﬁtness costs) was included as a random effect.
Data availability. Sequence data have been uploaded to the European Nucleotide Archive (acces-
sion IDs PRJEB33193 and PRJEB33233), and experimental data are available on Figshare (https://doi.org/
10.15131/shef.data.9692753.v1).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.01652-19.
FIG S1, PDF ﬁle, 0.01 MB.
TABLE S1, PDF ﬁle, 0.1 MB.
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